Oligonucleotide Synthesis Market Worth $16.7 Billion by 2027 - Exclusive Report by MarketsandMarkets™
Oligonucleotide Synthesis Market is projected to reach USD 16.7 billion by 2027 from USD 7.7 billion in 2022, at a CAGR of 16.8% during the forecast period according to a new report by MarketsandMarkets™. One of the key factors driving the market growth is the emerging field of personalized genome sequencing, which helps determine the best approach for patient care, whether preventive, diagnostic, or therapeutic. The incorporation of synthesized oligonucleotides to treat various diseases also supports market growth.
View full press release